BRIEF published on 03/19/2026 at 18:35, 7 months 21 days ago Oxurion annonce son intention d'acquérir une CRO internationale Acquisition Expansion Internationale Recherche Clinique Pharmaceutique Oxurion
PRESS RELEASE published on 03/19/2026 at 18:30, 7 months 21 days ago Oxurion signs a letter of intent for the acquisition of an international CRO Oxurion NV (Euronext Brussels: OXUR) announces the signing of a letter of intent for acquiring an international CRO, strengthening its clinical development strategy Acquisition Clinical Development Euronext Brussels CRO Oxurion NV
PRESS RELEASE published on 03/19/2026 at 18:30, 7 months 21 days ago Oxurion ondertekent een intentieverklaring voor de overname van een internationale CRO. Oxurion NV plant die Übernahme eines Mehrheitsanteils an einer internationalen CRO, um ihr integriertes klinisches Entwicklungsmodell zu stärken Übernahme Oxurion NV Mehrheitsanteil Klinische Entwicklung Internationale CRO
PRESS RELEASE published on 03/19/2026 at 18:30, 7 months 21 days ago Oxurion signe une lettre d'intention pour l'acquisition d'une CRO internationale Oxurion NV annonce l'acquisition potentielle d'une CRO internationale opérant en Europe, en Afrique du Nord et au Moyen-Orient pour renforcer son modèle dédié au développement clinique Stratégie Acquisition Développement Clinique Oxurion NV CRO Internationale
BRIEF published on 03/18/2026 at 18:05, 7 months 22 days ago Oxurion Acknowledges Transparency Notification from Atlas Pharmaceuticals Transparency Oxurion Belgian Legislation Atlas Investments
BRIEF published on 03/18/2026 at 18:05, 7 months 22 days ago Oxurion reçoit une notification de transparence d'Atlas Special Opportunities Transparence Financière Pharmaceutique Atlas Special Opportunities Investissements Digitaux Oxurion
BRIEF published on 03/18/2026 at 18:05, 7 months 22 days ago Oxurion receives a transparency notification from Atlas Special Opportunities Pharmaceutical Financial Transparency Atlas Special Opportunities Oxurion Digital Investments
BRIEF published on 03/18/2026 at 18:05, 7 months 22 days ago Oxurion accuse réception de la notification de transparence d'Atlas Transparence Médicaments Oxurion Législation Belge Atlas Investments
PRESS RELEASE published on 03/18/2026 at 18:00, 7 months 22 days ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV (Euronext Brussel: OXUR) ontvangt transparantiekennisgeving met betrekking tot aandelenbezit en kondigt ambitie aan om Europese farmaceutische onderaannemers te verwerven Transparantiekennisgeving Euronext Brussel Oxurion NV België Farmaceutische Onderaannemers
PRESS RELEASE published on 03/18/2026 at 18:00, 7 months 22 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC indicating a stake increase above the threshold. Oxurion specializes in acquiring pharmaceutical subcontractors Transparency Notification Oxurion NV Belgian Transparency Legislation Atlas Special Opportunities II Pharmaceutical Subcontractors
Published on 11/10/2026 at 12:45, 13 minutes ago Gamma Resources Announces Planned Radon Flux Baseline Survey at Mesa Arc Uranium Project in New Mexico, Provides Update on Project Timelines
Published on 11/10/2026 at 12:45, 13 minutes ago China Explores a New Pathway for Medical AI: Bridging R&D Innovation and Clinical Adoption
Published on 11/10/2026 at 12:35, 23 minutes ago Geek+ Unveils 24/7 Warehouse Autonomy Plan to Advance Self-Optimizing, Around-the-Clock Operation
Published on 11/10/2026 at 12:00, 58 minutes ago High Tide Produces 67.3% Fe Direct Reduction Quality Concentrate from Labrador West Pilot Plant Program
Published on 11/10/2026 at 12:00, 58 minutes ago Zomedica Announces "Third Friday at Four" Webinar on November 20, 2026: The People Behind Zomedica - Seven Guiding Principles in Action, and Q3 Financial Results
Published on 11/10/2026 at 12:45, 13 minutes ago Gabler Group AG Invites to Earnings Call on Unaudited Q3 2026 Results
Published on 11/10/2026 at 12:35, 22 minutes ago Cognizant dedicates more than 25,000 professionals to Claude delivery, introduces managed services model to run Claude at the core of enterprise operations
Published on 11/10/2026 at 12:05, 52 minutes ago EYKON is expanding the role of the meter at the grid edge
Published on 11/10/2026 at 12:05, 52 minutes ago EYKON launches Orkestra, a new software platform for modern utility operations
Published on 11/10/2026 at 11:16, 1 hour 41 minutes ago Second drill rig mobilised as Lionheart construction ramps up
Published on 11/10/2026 at 11:02, 1 hour 55 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 11:02, 1 hour 55 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Published on 11/10/2026 at 07:00, 5 hours 58 minutes ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/10/2026 at 07:00, 5 hours 58 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine et le marquage CE selon l’IVDR pour VITEK® PRO, son nouvel instrument automatisé d’identification et d’antibiogramme contribuant à la lutte contre l’antibiorésistance
Published on 11/09/2026 at 18:30, 18 hours 28 minutes ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
